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Abstract We compared the phagocytosis of immune complexes 
(IC) and iC3b-opsonized erivatives (iC3b-IC) by human neutro- 
phils. The phagocytosis of iC3b-IC via FcyR and CR3 was much 
greater than that of IC via FcTR alone. Adding ethanol to the 
cells decreased iC3b-IC phagocytosis to that of IC, which was not 
affected by these reagents, suggesting that the enhanced phagocy- 
tosis is attributable to CR3-mediated phospholipase D activation. 
1he IC phagocytosis was inhibited more effectively by anti- 
l:cyIIIB, whereas the iC3b-IC phagocytosis was partly inhibited 
only by anti-FcyRII. The main FcyR might differ in IC and 
iC3b-IC phagocytosis. 
Aey words." Neutrophil; Phagocytosis; FcyR; CR3; 
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1 Introduction 
Phagocytosis a fundamental effector function of human 
r, eutrophils that can be triggered by receptors for the Fc region 
( f IgG, FcyRII  (CD32) and FcyRII IB (CD16), and the recep- 
t)r  of C3, CR3 [1]. Fc~'RII is a transmembrane glycoprotein 
cf40 kDa [2] and FcTRIIIB is a glycosyl phosphatidylinositol- 
l~nked membrane protein of 50-70 kDa [3]. Whether FcyRII  
~nd FcyRIIIB differ in ligand binding specificity as well as in 
tileir ability to induce phagocytosis, has been the focus of con- 
sJderable investigation. When immune complexes (IC) activate 
tae complement system, they become opsonized with C3b, 
which is subsequently converted into iC3b by complement fac- 
t)rs I and H [4]. CR3 (CD1 lb/CD18) is a member of integrin 
lamily and is responsible for the binding and phagocytosis of
iC3b-opsonized IC, although signals through CR3 alone are 
19o weak to induce a significant phagocytic response in resting 
l~eutrophils [5]. In addition to the iC3b-binding domain, CR3 
~n neutrophils has a lectin-like domain through which it also 
~ cts as a pluripotent receptor in the recognition of zymosan [6], 
/ -glucan [7], and Escherichia coli [8]. 
The role of FcyR in the phagocytic response of neutrophils 
1 as mostly been studied by the use of IC or IgG-coated particles 
[)-12]. There are several lines of evidence suggesting that CR3 
i ~ concerned in the Fc~'R-mediated cellular esponses to IC by 
eutrophils. CR3-deficient neutrophils obtained from a patient 
with leukocyte adhesion deficiency syndromes howed de- 
pressed ability to phagocytose IgG-coated erythrocytes [13,14]. 
CR3 cocaps with FcyRIIIB through the lectin-like domain, and 
saccharides that inhibit cocapping also decrease IC-dependent 
transmembrane signaling and superoxide production [15,16]. 
Since FcyRIIIB is a glycosyl phosphatidylinositol-anchored 
membrane protein, CR3 is proposed to act as a membrane 
transducer for FcyRIIIB [16]. Furthermore, most of the IC 
formed in situ appear to be opsonized with iC3b before being 
processed by neutrophils [4]. Thus, iC3b-IC seems to be a useful 
ligand with which to assess FcyR-to-CR3 interaction in the 
phagocytic response of neutrophils. However, little is known 
about the contribution of CR3-derived signal transduction to 
FcyR-mediated cellular esponses using the ligand, iC3b-IC. 
This study was designed to compare the phagocytic re- 
sponses to IC, iC3b-IC, and iC3b-IC[F(ab')2 ] by neutrophils, 
in which iC3b-IC is supposed to cross-link FcyR and CR3, 
whereas IC and iC3b-IC[F(ab')2] bind with only FcyR and 
CR3, respectively. In addition, CR3-mediated cellular re- 
sponses are reportedly coupled to the activation of phospholip- 
ase D (PLD) [17]. Thus, ethanol and propranolol, which inhibit 
PLD-mediated cellular responses in neutrophils [18,19], were 
used to evaluate the effects of CR3-mediated responses upon 
phagocytosis of IC and iC3b-IC by neutrophils. 
2. Materials and methods 
2.1. Preparation of human neutrophils 
Human peripheral blood was collected from healthy volunteers in 
acid citrate-dextrose. Neutrophils were isolated by sedimentation using 
Dextran T-500 and Ficoll-Paque (Pharmacia Biotech, Uppsala, Swe- 
den), followed by the hypotonic lysis of contaminating erythrocytes a  
reported [12,20]. 
2.2. Antibodies 
The Fab fragment of a monoclonal antibody (mAb) (IV.3) to FcyR 
II and the F(ab')2 fragment ofa mAb (3G8) to FcyRIII were purchased 
from Medrex (New Hampshire, USA). The mAb to CR3 (#44) was 
obtained from Leinco Technologies (Ballwin, USA). Human anti-teta- 
nus toxoid IgG was obtained from Green Cross (Osaka, Japan). The 
pepsin fragment F(ab')2 of human anti-tetanus toxoid IgG was pre- 
pared by incubating anti-tetanus IgG with pepsin at a substrate/enzyme 
ratio of 50 : 1 (w/w) at pH 4.5 for 24 h at 37°C. The digest was passed 
through acolumn containing protein A-Sepharose, and the eluate was 
collected and used as F(ab')2. The absence of uncleaved IgG in the 
F(ab')2 preparation was confirmed by SDS-PAGE. 
'Corresponding author. Fax: (81) (l 1) 706 4989. 
. Ibbreviations: IC, immune complexes; iC3b-IC, iC3b-opsonized IC; 
I'LD, phospholipase D; FITC, fluorescein isothiocyanate; FIC, FITC- 
1 tbeled IC; mAb, monoclonal antibody. 
2.3. Preparation of lC and FITC-labeled 1C 
FITC-labeled or -unlabeled IC were prepared as reported [12,21], 
with FITC-labeled or -unlabeled tetanus toxoid and human anti-teta- 
nus toxoid IgG. Tetanus toxoid, which was a gift from Prof. T. Ki- 
noshita, the Research Institute for Microbial Diseases, Osaka Univer- 
sity, was labeled with fluorescein sothiocyanate (FITC, Sigma Chemi- 
1,014-5793/95l$9.50 © 1995 Federation of European Biochemical Societies. All rights reserved. 
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cal Co.) as reported [12]. FITC-labeled IC[F(ab')2 ] (FIC[F(ab')2]) was 
prepared with FITC-labeled tetanus toxoid and anti-tetanus F(ab')2 at 
equivalence asdescribed above. 
2.4. Preparation of iC3b-FIC and iC3b-FIC[F(ab')2] 
Fifty micrograms ofFIC or FIC[F(ab')2 ] was incubated with 300 fll 
of human serum without or with 10 mM EGTA-5 mM MgClz for 60 
min at 37°C. During this incubation, complement activation proceeded 
on FIC and FIC[F(ab')2] to opsonize the complexes with C3b, which 
was immediately converted into iC3b, a true ligand for CR3. 
2.5. SDS-PAGE 
Samples were reduced with 2-mercaptoethanol dresolved by SDS- 
PAGE [22]. Gels were stained with Coomassie brilliant blue. Molecular 
mass markers were obtained from Pharmacia (Uppsala, Sweden), and 
iC3b was prepared by incubating C3b with factor H and I [23]. 
2.6. Assay of association and phagocytosis 
The association and phagocytosis of FIC derivatives was measured 
by a flow cytometer asdescribed [12,21]. Neutrophils (5x 105 cells) were 
brought to 250/A with Krebs-Ringer-phosphate buffer and mixed with 
FIC derivatives ata final concentration f25/zg/ml (FIC equivalent 
determined bydensitometry after SDS-PAGE). After an incubation for 
20 rain at 37°C, the cells were washed twice, then the amounts of 
cell-bound FIC were determined using a flow cytometer (EPICS-CS 
Coulter Co.). For the phagocytosis a say, neutrophils (5x 105 cells) in 
250/zl of Krebs-Ringer-phosphate buffer were incubated with FIC at 
25 jzg/ml for 20 min at 37°C, then chilled at 0°C. The cells were washed 
twice with cold phosphate-buffered saline, suspended in 20 mM sodium 
acetate buffer, pH 4.5, containing 150 mM NaC1 and 0.5 mg/ml of 
Trypan blue to quench the fluorescence at the cell surface. The un- 
quenchable fluorescence due to intracellular FIC was determined by 
flow cytometry. 
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Fig. 1. SDS-PAGE analysis of FIC, iC3b-FIC, FIC[F(ab')2] and iC3b- 
FIC[F(ab')2]. FIC or FIC[F(ab')~] was incubated with human serum 
containing 10 mM EGTA-5 mM MgCI2 for 60 min at 37°C. After 
washing, these ligands, FIC (1), iC3b-FIC (2), FIC[F(ab')z] (3), iC3b- 
FIC[F(ab')2] (4), and iC3b (5), were resolved by SDS-PAGE (10% gel) 
under educing conditions. The gels were stained with Coomassie bril- 
liant blue. Molecular mass markers in kDa are shown on the left. 
Arrows at the right margin: (a), covalent complex of iC3b 0q chain and 
IgG H chain; (b), covalent complex of iC3b ~ chain and F(ab')2 Fd 
chain; (c), iC3b fl chain; (d), iC3b ~ chain; (e), IgG H chain; (f), iC3b 
~2 chain; (g), F(ab')2 Fd chain; (h), IgG L chain. 
3. Results 
3.1. Effect of the opson&ation of FIC with iC3b upon 
phagoeytos& by neutrophils 
Incubating FIC[F(ab'):] as well as FIC with human serum 
results in the covalent binding of C3b through activation of the 
complement pathway. The C3b on FIC[F(ab')2] and FIC is 
immediately cleaved by complement factors, H and I, to form 
iC3b-FIC[F(ab')2] or iC3b-FIC; iC3b is composed of three di- 
sulfide-linked polypeptide chains, ~ (68 kDa), ~2 (43 kDa), and 
fl (70 kDa) [24]. SDS-PAGE of the serum-treated, reduced 
complexes revealed bands of 70 and 43 kDa, that corresponded 
to the fl and ~2 chains, respectively, of iC3b (Fig. 1). The ~ 
chain of iC3b was not detectable, because iC3b binds through 
the ~1 chain with the H chain of IgG or the Fd of F(ab')2. 
Judging from the relative dye intensities of the H chain of IgG 
(the Fd of F(ab')2) and the fl chain of iC3b, the apparent molar 
ratio of IgG and iC3b was assumed to be 1 : 1. These iC3b- 
Table 1 
Interaction of three ligands with neutrophils 
Stimulants Association Phagocytosis Incorporated 
(F.I.) (F.I.) F.I. (%) 
FIC 32.8 +_ 9.4 4.2 + 0.8 12.9 
iC3b-FIC 176.2 + 32.6 38.0 + 7.8 21.6 
iC3b- 6.6 + 2.9 2.0 + 0.5 30.0 
FIC[F(ab')z] 
Neutrophils (5 x 105 cells) were incubated with each of the three ligands 
for 20 min at 37°C. In the phagocytosis a say, the cell suspensions were 
then rapidly chilled to 0°C in an ice bath, mixed with Trypan blue at 
pH 4.5 to quench the extracellular fluorescence, and analyzed by flow 
cytometry. The percent of incorporated fluorescence was the ratio of 
Phagocytosis F.I./Association F.I. at 37°C for 20 min. The data are the 
means with S.E.M. for three xperiments 
opsonized ligands as well as free FIC were used to assess CR3- 
and FcyR-dependent phagocytosis by neutrophils. 
The phagocytosis of these ligands was time-dependent (2.5- 
20 min) (data not shown). Table 1 summarizes the association 
and phagocytosis ofthe three ligands when assayed after 20 min 
incubation. The association and phagocytosis of iC3b-FIC was 
much greater than those of either FIC or iC3b-FIC[F(ab')2] 
alone. However, simultaneously incubating iC3b-FIC[F(ab')2] 
(25/,tg/ml)-treated n utrophils with unlabeled IC (50/ag/ml) did 
not enhance the phagocytosis of iC3b-FIC[F(ab')2] (data not 
shown). These results uggested that the enhanced phagocyto- 
sis of iC3b-FIC requires the cross-linking ofCR3 and FcyR on 
neutrophils. Table 1 also demonstrates the ratio of intracellular 
to cell-bound fluorescence intensity, which reflects the rate of 
incorporation of receptor-bound ligand. The highest fluores- 
cence ratio was given by iC3b-FIC[F(ab')2], which had the 
lowest level of association as well as phagocytosis. This sug- 
gested that CR3-mediated phagocytosis proceeds more rapidly 
than that mediated by Fc?'R, although CR3-dependent iC3b- 
FIC[F(ab')z] association with neutrophils is lower than the 
Fc?'R-dependent FIC association with the cells. 
3.2. Effect of ethanol and propranolol upon Fc~R- and 
CR3-mediated phagocytosis 
CR3-mediated cellular esponses are reportedly coupled with 
the activation of PLD, which hydrolyzes phosphatidylcholine 
to accumulate diglyceride [17]. In the presence of ethanol, PLD 
activation results in the formation of phosphatidylethanol 
through a transphosphatidylation reaction together with a de- 
crease in phosphatidic a id generation [18]. We investigated the 
effect of ethanol upon the phagocytosis of iC3b-FIC[F(ab')2] 
by neutrophils. Phagocytosis of the ligand by neutrophils 
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I- ig. 2. Effect of ethanol or propranolol on phagocytosis of FIC or 
i( ;3b-FIC by neutrophils. Neutrophils (5 x 10 ~ cells) were incubated 
x~ ith various concentrations ofethanol (A), or propranolol (B) for 5 rain 
a 37°C, then with FIC (~)), iC3b-FIC (e) for 20 rain at 37°C. The data 
a "e the mean with S.E.M. of three experiments. 
was dose-dependently inhibited by ethanol (data not shown): 
~,8% inhibition was caused in cells preincubated with 0.7% 
ethanol. On the other hand, the enhanced phagocytosis of 
iC3b-FIC by neutrophils decreased with increasing ethanol 
oncentration, close to the level of FcyR-mediated phagocyto- 
v~s of FIC, which was not inhibited by ethanol (Fig. 2A). Expo- 
s, are to 0.7% ethanol did not affect the viability of neutrophils 
~,nd the association of FIC and iC3b-FIC. In addition, propra- 
l olol, which inhibits the production of diglyceride from 
t,hosphatidic acid [19,25], suppressed the enhanced phagocyto- 
~is of iC3b-FIC to the same level as that of FIC (Fig. 2B). Thus 
~tlese results uggested that the accumulation of diglyceride by 
I 'LD is critical for the enhanced phagocytosis of iC3b-FIC by 
:~eutrophils. 
• .3. Effect ofanti-Fc~'R and anti-CR3 on phagocytosis of FIC 
and iC3b-FIC by neutrophils 
Resting neutrophils prepared from peripheral blood express 
~wo types of FcyR, FcyRII  (CD32) and FcyRIIIB (CD16). 
incubating neutrophils with anti-Fc),RII (IV.3) and anti- 
!:cyRIIIB (3G8) decreased the phagocytosis of FIC to 86 and 
~9%, respectively, of that of control cells (Table 2). Incubating 
~eutrophils with both anti-FcyR completely inhibited phagocy- 
'osis. These results suggested that although both FcyRII  and 
=cyRIIIB are concerned in the phagocytosis of FIC, Fc),RIIIB 
s the main receptor in the phagocytosis of FIC. On the con- 
rary, the phagocytosis of iC3b-FIC was inhibited partially by 
mti-FcyR II (47%) but not by anti-FcyRIIIB, which did not 
nhibit the anti-Fc),RII-resistant phagocytosis. These results 
,uggested that different subclasses of FcyR are responsible for 
he processing of FIC and iC3b-FIC. Anti-CR3, mAb 44, inhib- 
ted the phagocytosis of iC3b-FIC to 50% of that of control. 
Fhe anti-CR3-resistant phagocytosis ofiC3b-FIC was inhibited 
)y anti-FcyRII and -IIIB to 14% of that of control. These 
'esults suggest hat FcyRII- and CR3-mediated cellular re- 
sponses contribute qually to the phagocytosis of iC3b-FIC by 
aeutrophils. To confirm the role of the CR3-mediated cellular 
'esponse in the phagocytosis of iC3b-FIC, ethanol was used as 
an inhibitor of CR3-mediated responses. The anti-Fc),RII-re- 
dstant phagocytosis of iC3b-FIC was almost completely inhib- 
ted by ethanol. 
4. Discussion 
It has been proposed that synergism between FcyR and CR3 
is important in the processing of IC by neutrophils. We inves- 
tigated the functional association between FcyR and CR3 
using iC3b-opsonized IC, because IC formed in situ are likely 
to be in the form of iC3b-IC. We are the first to assess yner- 
gism between FcyR and CR3 in the phagocytic responses of 
human neutrophils using the FITC-labeled ligands; FIC, iC3b- 
FIC, and iC3b-FIC[F(ab')2]. 
Neutrophils howed enhanced association and phagocytosis 
of iC3b-FIC compared with those of FIC. The independent 
activation of FcyR and CR3 of neutrophils by IC and iC3b- 
FIC[F(ab'h] did not enhance the CR3-mediated phagocytosis 
of iC3b-FIC[F(ab')2] to the level of iC3b-FIC, suggesting that 
the cross-linking of CR3 and FcyR by iC3b-FIC is required for 
the enhancement of CR3-mediated phagocytosis. Evidence that 
the enhanced phagocytosis of iC3b-FIC is decreased by treating 
neutrophils with ethanol or propranolol to the level of phagocy- 
tosis of FIC suggests that CR3-mediated signal transduction is 
responsible for the enhanced phagocytosis of iC3b-FIC. 
CR3-dependent cellular esponses are mediated by PLD acti- 
vation [17], and exposure to ethanol results in a decrease in 
phosphatidic acid generation [18]. The phagocytosis of iC3b- 
FIC as well as iC3b-FIC[F(ab')2] was inhibited by incubating 
neutrophils with ethanol, though ethanol did not affect FcyR- 
mediated phagocytosis. These results uggested that FcyR and 
CR3 use different signal transduction systems for their 
phagocytic responses. Propranolol, which inhibits the produc- 
tion of diglyceride from phosphatidic acid [19,25], also inhibited 
the CR3-mediated phagocytosis, indicating that the activation 
of protein kinase C by diglyceride is responsible for the CR3- 
mediated phagocytosis~ 
An additional effect of the iC3b-binding to IC is the shift of 
the major FcyR responsible for the phagocytic response. 
Phagocytosis of FIC by neutrophils was inhibited by anti- 
FcyRIIIB more effectively than anti-FcyRII, suggesting that 
Table 2 
Effect of anti-FcgRs, anti-CR3 and ethanolon the phagocytosis ofFIC 
or iC3b-FIC by neutrophils 
Stimulants mAb or ethanol (EtOH) Phagocytosis 
(% of control) 
FIC none 100 
IV.3 86.2 + 14.2 
3G8 39.4 + 7.3 
IV.3 + 3G8 2.6 + 1.1 
iC3b-FIC none 100 
UV.3 47.8 _+ 3.1 
3G8 105.1 + 1.5 
44 49.7 + 12.5 
IV.3 + 3G8 48.7 + 5.0 
IV.3 + 3G8 + 44 14.4 + 4.4 
EtOH 38.6_+ 1.9 
IV.3 + EtOH 7.0 _+ 1.5 
3G8 + EtOH 45.1 _+ 2.7 
IV.3 + 3G8 + EtOH 6.2 + 1.2 
Neutrophils (5 × 105 cells) were incubated with the indicated anti- 
FcyRs or anti-CR3 (2 pg/ml) for 30 min at 4°C. Cell suspensions were 
incubated with 0.7% ethanol for 5 min at 37°C, then with each of the 
stimulants at 37°C for 20 min. The data are the means with S.E.M. of 
three experiments and are given as the percentage of the phagocytic 
activity obtained from non-treated cells 
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FcyRIIIB is the major receptor responsible for the phagocyto- 
sis of IC. This supported the observations of Brunkhorst et al. 
[9], but seems to be in conflict with that of Huizinga et al. [10] 
and Edberg and Kimbery [11], who showed that FcT/RII is 
much more efficient than FcyRIIIB in initiating the phagocyto- 
sis of IC. The reason for this discrepancy would be due to the 
difference in the size of IC; the latter groups used a large IC 
composed of Staphylococcus aureus [10] and erythrocytes [l 1]. 
Blocking FcTRII with mAb IV.3 is reportedly imperfect be- 
cause the mAb IV.3 is easily expelled from the Fc~'RII by excess 
IC [10]. This could explain the partial inhibition of phagocytosis 
of iC3b-FIC by mAb IV.3. The reason for the differential 
binding of FIC and iC3b-FIC to FcyRII  and FcyRIIIB is 
difficult to explain. However, it may be that the covalent bind- 
ing of iC3b to FIC induces a conformational change in the Fc 
domain to alter the binding affinity between the Fc and FcyR. 
Evidence that the binding ofiC3b-FIC to neutrophils i temper- 
ature dependent and requires divalent cations (data not shown), 
as is the interaction between iC3b and CR3 [26], may reflect a 
decrease in the affinity between FcT/R and the Fc domain of 
iC3b-FIC. At any rate, FcyRII  but not FcyRIIIB was func- 
tionally associated with CR3 during the processing of iC3b- 
opsonized IC by neutrophils. 
Zhou and Brown have reported that a respiratory burst oc- 
curs when human neutrophils are plated on a surface coated 
with both anti-CR3 and anti-FcyRIIIB mAb [27]. This respira- 
tory burst stimulated by synergy between FcyRIIIB and CR3 
is completely inhibited by anti-FcyRII. Further analysis reveals 
that FcT/RII is phosphorylated on tyrosine only when both 
CR3 and Fc~,RIIIB are ligated [27]. It is possible that tyrosine- 
phosphorylation of FcyRII  enhances the binding between 
FcyRIl  and iC3b-FIC. Further investigations are required to 
understand the precise molecular mechanism of the synergy 
between Fc~'R and CR3 in the activation ofneutrophils effector 
functions, including phagocytosis. 
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